These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15728905)

  • 1. Synthesis and antileishmanial activities of novel 3-substituted quinolines.
    Tempone AG; da Silva AC; Brandt CA; Martinez FS; Borborema SE; da Silveira MA; de Andrade HF
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1076-80. PubMed ID: 15728905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinoline derivatives: Synthesis, leishmanicidal activity and involvement of mitochondrial oxidative stress as mechanism of action.
    Coimbra ES; Antinarelli LM; Silva NP; Souza IO; Meinel RS; Rocha MN; Soares RP; da Silva AD
    Chem Biol Interact; 2016 Dec; 260():50-57. PubMed ID: 27789199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase transfer catalyzed synthesis of bis-quinolines: antileishmanial activity in experimental visceral leishmaniasis and in vitro antibacterial evaluation.
    Palit P; Paira P; Hazra A; Banerjee S; Gupta AD; Dastidar SG; Mondal NB
    Eur J Med Chem; 2009 Feb; 44(2):845-53. PubMed ID: 18538452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel organic salts based on quinoline derivatives: The in vitro activity trigger apoptosis inhibiting autophagy in Leishmania spp.
    Calixto SL; Glanzmann N; Xavier Silveira MM; da Trindade Granato J; Gorza Scopel KK; Torres de Aguiar T; DaMatta RA; Macedo GC; da Silva AD; Coimbra ES
    Chem Biol Interact; 2018 Sep; 293():141-151. PubMed ID: 30098941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileishmanial activity of Eugenol-rich essential oil from Ocimum gratissimum.
    Ueda-Nakamura T; Mendonça-Filho RR; Morgado-Díaz JA; Korehisa Maza P; Prado Dias Filho B; Aparício Garcia Cortez D; Alviano DS; Rosa Mdo S; Lopes AH; Alviano CS; Nakamura CV
    Parasitol Int; 2006 Jun; 55(2):99-105. PubMed ID: 16343984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antileishmanial 2-substituted quinolines: in vitro behaviour towards biological components.
    Desrivot J; Herrenknecht C; Ponchel G; Garbi N; Prina E; Fournet A; Bories C; Figadère B; Hocquemiller R; Loiseau PM
    Biomed Pharmacother; 2007 Aug; 61(7):441-50. PubMed ID: 17459651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents.
    Gopinath VS; Pinjari J; Dere RT; Verma A; Vishwakarma P; Shivahare R; Moger M; Kumar Goud PS; Ramanathan V; Bose P; Rao MV; Gupta S; Puri SK; Launay D; Martin D
    Eur J Med Chem; 2013 Nov; 69():527-36. PubMed ID: 24095747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis and Antileishmanial Activity of Naphthotriazolyl-4- Oxoquinolines.
    Oliveira VG; Dos Santos Faiões V; Gonçalves GBR; Lima MFO; Boechat FCS; Cunha AC; de Andrade-Neto VV; de C da Silva F; Torres-Santos EC; de Souza MCBV
    Curr Top Med Chem; 2018; 18(17):1454-1464. PubMed ID: 30277154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships and mechanistic studies of novel mitochondria-targeted, leishmanicidal derivatives of the 4-aminostyrylquinoline scaffold.
    Staderini M; Piquero M; Abengózar MÁ; Nachér-Vázquez M; Romanelli G; López-Alvarado P; Rivas L; Bolognesi ML; Menéndez JC
    Eur J Med Chem; 2019 Jun; 171():38-53. PubMed ID: 30904756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory activity of limonene against Leishmania parasites in vitro and in vivo.
    Arruda DC; Miguel DC; Yokoyama-Yasunaka JK; Katzin AM; Uliana SR
    Biomed Pharmacother; 2009 Nov; 63(9):643-9. PubMed ID: 19321295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antileishmanial and antitrypanosomal activities of flavanones from Baccharis retusa DC. (Asteraceae).
    Grecco Sdos S; Reimão JQ; Tempone AG; Sartorelli P; Cunha RL; Romoff P; Ferreira MJ; Fávero OA; Lago JH
    Exp Parasitol; 2012 Feb; 130(2):141-5. PubMed ID: 22143090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure/antileishmanial activity relationship study of naphthoquinones and dependency of the mode of action on the substitution patterns.
    Ali A; Assimopoulou AN; Papageorgiou VP; Kolodziej H
    Planta Med; 2011 Dec; 77(18):2003-12. PubMed ID: 21800278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani.
    Yousuf M; Mukherjee D; Dey S; Pal C; Adhikari S
    Eur J Med Chem; 2016 Nov; 124():468-479. PubMed ID: 27598235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives.
    Peyron C; Benhida R; Bories C; Loiseau PM
    Bioorg Chem; 2005 Dec; 33(6):439-47. PubMed ID: 16168460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pyrazoloquinoline derivatives on the growth of Leishmania donovani promastigotes.
    Al-Qahtani A; Siddiqui YM; Bekhit AA; El-Sayed OA; Aboul-Enein HY; Al-Ahdalb MN
    Arch Pharm (Weinheim); 2005 Oct; 338(10):484-7. PubMed ID: 16211660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases.
    Nakayama H; Loiseau PM; Bories C; Torres de Ortiz S; Schinini A; Serna E; Rojas de Arias A; Fakhfakh MA; Franck X; Figadère B; Hocquemiller R; Fournet A
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4950-6. PubMed ID: 16304157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents.
    Guillon J; Forfar I; Mamani-Matsuda M; Desplat V; Saliège M; Thiolat D; Massip S; Tabourier A; Léger JM; Dufaure B; Haumont G; Jarry C; Mossalayi D
    Bioorg Med Chem; 2007 Jan; 15(1):194-210. PubMed ID: 17049253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of mesoionic compounds in Leishmania sp. and toxicity evaluation.
    Rodrigues RF; da Silva EF; Echevarria A; Fajardo-Bonin R; Amaral VF; Leon LL; Canto-Cavalheiro MM
    Eur J Med Chem; 2007 Jul; 42(7):1039-43. PubMed ID: 17367894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of synthetic tetrahydroindeno[2,1-c]quinolines on Leishmania mexicana.
    Hernández-Chinea C; Carbajo E; Sojo F; Arvelo F; Kouznetsov VV; Romero-Bohórquez AR; Romero PJ
    Parasitol Int; 2015 Dec; 64(6):479-83. PubMed ID: 26148815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileishmanial activity and ultrastructural alterations of Leishmania (L.) chagasi treated with the calcium channel blocker nimodipine.
    Tempone AG; Taniwaki NN; Reimão JQ
    Parasitol Res; 2009 Aug; 105(2):499-505. PubMed ID: 19352709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.